Skip to main content
. 2017 Dec;11(12):811–822.e2. doi: 10.1016/j.jash.2017.10.003

Table S1.

Comparison of baseline characteristics between individuals in analytic sample and those excluded from the analysis

Variable n Analytic Sample (n = 539) Excluded (n = 802) P Value
Age, mean (SD) 50.9 (9.06) 55.9 (12.2) <.001
Female, n (%) 340 (63.1) 500 (62.3) .78
Education, n (%) <.001
 Formal 358 (66.2) 429 (53.5)
 Not formal 181 (33.6) 373 (46.5)
BMI (kg/m2, mean, SD) 1337 27.7 (5.0) 26.0 (5.5) <.001
SBP (mm Hg, mean, SD) 149.1 (22.6) 153.2 (25.6) .002
DBP (mm Hg, mean, SD) 92.9 (12.3) 93.1 (13.6) .78
ARB or ACEI, n (%) 71 (13.2) 112 (14.0) .68
β-Blocker, n (%) 119 (22.1) 153 (19.1) .18
CCB, n (%) 51 (9.5) 78 (9.7) .87
Diuretics, n (%) 12 (2.2) 27 (3.4) .22
Diabetes, n (%) 1279 129 (23.9) 241 (32.6) <.001
Heart disease, n (%) 1334 64 (11.9) 119 (14.8) .11
Smoking, n (%) <.001
 Never 333 (61.8) 401 (50.0)
 Current or past 206 (38.2) 401 (50.0)
LDL (mg/dL, mean, SD) 1271 120.4 (32.9) 118.9 (32.4) .40
HDL (mg/dL, mean, SD) 1271 40.3 (10.3) 40.9 (10.7) .31
Triglyceride (mg/dL, mean, SD) 1271 179.4 (102) 165 (84.1) .007
eGFR (mL/min/1.73 m2, mean, SD) 1271 91.0 (15.9) 84.2 (20.9) <.001
UACR (mg/g, median, IQR) 1272 6.2 (3.9, 11.3) 6.9 (4.4, 19.7) <.001
Intervention group, n (%) <.001
 No intervention 137 (25.4) 189 (23.6)
 GP only 107 (19.9) 228 (28.4)
 HHE only 129 (23.9) 219 (27.3)
 GP and HHE 166 (30.8) 166 (20.7)

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; CCB, calcium channel blocker; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; GP, general practitioner; HDL, high-density lipoprotein; HHE, home health education; IQR, interquartile range; LDL, low-density lipoprotein; SBP, systolic blood pressure; SD, standard deviation; UACR, urine albumin-to-creatinine ratio.